Long-term efficacy and safety of tacalcitol ointment in patients with chronic plaque psoriasis

British Journal of Dermatology

Volumn 146, Issue 3, 2002, Pages 414-422

  Van De Kerkhof, P C M ^a   Berth Jones, J ^b   Griffiths, C E M ^c   Harrison, P V ^d   Honigsmann H ^e   Marks, R ^f   Roelandts, R ^g   Schopf E ^h   Trompke, C ⁱ  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b WALSGRAVE HOSPITAL   (United Kingdom)

^c HOPE HOSPITAL   (United Kingdom)

^d Queen Victoria Hospital   (United Kingdom)

^e UNIVERSITY OF VIENNA   (Austria)

^f Skin Care Cardiff Ltd   (United Kingdom)

^g UZ Sint Rafael   (Belgium)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ Medical Clinical Affairs   (Germany)

Author keywords

Calcium homeostasis; Long term treatment; Plaque psoriasis; Tacalcitol

Indexed keywords

ALPHA 1 MICROGLOBULIN; CALCITONIN; CALCITRIOL; CALCIUM; CREATININE; PARATHYROID HORMONE; TACALCITOL;

ADULT; AGED; ARTICLE; BODY SURFACE; CALCITONIN BLOOD LEVEL; CALCIUM BLOOD LEVEL; CALCIUM HOMEOSTASIS; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE URINE LEVEL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OINTMENT; PARAMETER; PARATHYROID HORMONE BLOOD LEVEL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PSORIASIS; SKIN IRRITATION; VITAMIN BLOOD LEVEL;

EID: 0036277786     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04567.x     Document Type: Article

References (33)

1. A simple treatment for psoriasis
2. The treatment of psoriasis with various vitamin D preparations
3. 3
4. A double-blind, placebo controlled trial of topical 1.25 dihydroxycholecalciferol in psoriasis
5. Successful therapy with 'calcipotriol' in a patient with therapy resistant psoriatic lesions
6. Calcipotriol: A review of its pharmacological properties and therapeutic efficacy in the management of psoriasis
7. 3 analogues
8. 3 analogues in the treatment of psoriasis
9. The emergence of vitamin D as a first-line treatment for psoriasis
10. 3 analogue for psoriasis
11. 3 on the growth of human keratinocytes
12. 3 for the treatment of psoriasis. Review of the literature
13. Tacalcitol
14. Optimal concentration of tacalcitol in once-daily treatment of psoriasis
15. Tacalcitol ointment in the treatment of psoriasis vulgaris: A multicentre, placebo-controlled, double-blind study on efficacy and safety
16. Tacalcitol ointment is an efficacious and well tolerated treatment for psoriasis
17. Long-term efficacy and safety of once daily treatment of chronic plaque psoriasis with tacalcitol ointment
18. A long-term assessment of the safety and tolerability of calcitriol ointment in the treatment of chronic plaque psoriasis
19. Severe psoriasis - Oral therapy with a new retinoid
20. Tacalcitol and skin irritation
21. 3-analogon tacalcitol
22. Current experience with tacalcitol ointment in the treatment of psoriasis
23. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial
24. Long-term use of topical calcipotriol in chronic plaque psoriasis
25. Topical tacalcitol treatment for psoriasis
26. High dose tacalcitol in the treatment of extensive psoriasis
27. Current understanding of the molecular actions of vitamin D
28. High dose topical calcipotriol consistently reduces serum parathyroid hormone levels
29. The effects of topical calcipotriol on systemic homeostasis in patients with chronic plaque psoriasis
30. Urine calcium excretion during treatment of psoriasis with topical calcipotriol